Research

Equity Research
ISRG
Intuitive Surgical Stock Analysis: Valuation, Procedure Growth, China Risk & Cash Flow
Jun 10, 2026
Intuitive Surgical (ISRG) earns a HOLD rating as its dominant installed base and recurring revenue continue to support strong cash generation. However, the stock already prices in durable execution at a rich valuation, with China tender delays and pricing pressure clouding near-term upside.
Read note
Equity Research
UTF
Utility Income Fund Stock Analysis: Valuation, Cash Flow, Leverage & Liquidity
Jun 10, 2026
Utility Income Fund (UTF) earns a HOLD rating as its 6.8x trailing P/E and strong operating margin are offset by weak cash generation and tight liquidity. The fund can work if cash conversion improves, but negative operating cash flow and leverage remain the key risks.
Read note
Equity Research
CELH
Celsius Holdings Stock Analysis: Valuation, Free Cash Flow, Pepsi Risk & Margins
Jun 10, 2026
Celsius Holdings (CELH) is rated HOLD as strong revenue growth, free cash flow, and a rebound in EBITDA are offset by heavy Pepsi dependence. The stock looks reasonably valued, but concentration risk remains the main overhang as management works to sustain margin recovery.
Read note
SEC What Changed
SEC
SEC What Changed: 10-K Filing Snapshot for 10 June 2026
Jun 10, 2026
A ranked snapshot of 10-K language changes for companies that filed annual reports on 10 June 2026.
Read note
Equity Research
WLDN
Willdan Group Stock Analysis: Valuation, Margins, Cash Flow & Leverage
Jun 9, 2026
Willdan Group, Inc. (WLDN) earns a HOLD rating as solid procurement access and a clean balance sheet are offset by a rich valuation. With 23.9x EV/EBITDA and only 4.7% operating margin, execution and backlog conversion are critical.
Read note
Equity Research
GE
General Electric Stock Analysis: Valuation, Margins, Leverage & Cash Flow
Jun 9, 2026
General Electric (GE) earns a HOLD rating as strong margins and cash generation are offset by a premium valuation. The company’s 40.4x trailing P/E and 31.4x EV/EBITDA leave little room for execution misses, especially with elevated leverage and a thin liquidity cushion.
Read note
Equity Research
PATH
UiPath Stock Analysis: Valuation, ARR Growth, Retention & Free Cash Flow
Jun 9, 2026
UiPath (PATH) earns a HOLD rating as its valuation already reflects a better monetization and margin story. ARR growth slowed to 11% and dollar-based net retention slipped to 107%, leaving execution and retention as the key watchpoints.
Read note
Equity Research
ABT
Abbott Laboratories Stock Analysis: Buy or Sell? Valuation & FCF
Jun 9, 2026
Abbott Laboratories (ABT) is rated Hold as quality fundamentals and $7.2B of levered free cash flow are offset by softer Q1 2026 EBITDA and a valuation that already looks fair to slightly rich. Exact Sciences integration risk and 2.32x net debt/EBITDA keep the upside case restrained.
Read note
Equity Research
VZ
Verizon Stock Analysis: VZ Beta, Dividend Safety & Valuation
Jun 9, 2026
Verizon Communications Inc. (VZ) earns a HOLD rating as its defensive cash flow and 7.5x EV/EBITDA valuation are offset by heavy leverage. Q1 2026 EBITDA rose 7.3% year over year, but $200.9B of debt keeps refinancing risk front and center.
Read note
Equity Research
FSLY
Fastly, Inc. (FSLY) Edge Cloud Platform — Equity Research
Jun 9, 2026
Fastly, Inc. (FSLY) is rated a constructive hold on its programmable edge cloud platform and durable gross margins. Positive free cash flow and 81% gross margin support the thesis, though debt and customer concentration remain key risks.
Read note

Get future lf0 research notes by email.

Equity research, scorecards, weekly performance updates, and SEC filing-change summaries.

Subscribe to lf0 Research Notes